Faithward Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Buy
+1,160
New +$240K 0.03% 314
2026
Q1
Sell
-1,283
Closed -$309K 322
2025
Q4
$309K Sell
1,283
-39
-3% -$9.97K 0.05% 255
2025
Q3
$362K Buy
1,322
+6
+0.5% +$1.64K 0.05% 225
2025
Q2
$340K Buy
1,316
+16
+1% +$3.82K 0.05% 207
2025
Q1
$291K Buy
1,300
+21
+2% +$4.9K 0.05% 213
2024
Q4
$292K Buy
1,279
+53
+4% +$12.8K 0.05% 207
2024
Q3
$299K Buy
1,226
+11
+0.9% +$2.46K 0.05% 222
2024
Q2
$233K Sell
1,215
-56
-4% -$11.4K 0.04% 230
2024
Q1
$252K Buy
+1,271
New +$233K 0.05% 221
2022
Q3
Sell
-1,689
Closed -$354K 267
2022
Q2
$354K Sell
1,689
-246
-13% -$52.4K 0.08% 108
2022
Q1
$470K Sell
1,935
-178
-8% -$43.1K 0.09% 103
2021
Q4
$550K Sell
2,113
-1,500
-42% -$389K 0.1% 93
2021
Q3
$952K Sell
3,613
-1,160
-24% -$317K 0.18% 71
2021
Q2
$1.18M Sell
4,773
-12,734
-73% -$2.68M 0.23% 57
2021
Q1
$3.4M Buy
+17,507
New +$3.51M 0.76% 35
2020
Q4
Sell
-22,559
Closed -$3.87M 197
2020
Q3
$3.87M Sell
22,559
-4,214
-16% -$778K 0.94% 37
2020
Q2
$5.14M Buy
26,773
+5,025
+23% +$822K 1.33% 21
2020
Q1
$3.2M Buy
21,748
+19,762
+995% +$3.15M 0.9% 25
2019
Q4
$308K Buy
+1,986
New +$286K 0.07% 129

Other funds holding RMD

Faithward Advisors's RMD Position: Q2 2026 in Review

Faithward Advisors opened a new position in ResMed (RMD) in Q2 2026: 1,160 shares worth $226K. The stake represents 0.03% of the portfolio and ranks #314 among its holdings. This is a return to the name: Faithward Advisors previously reported a position in RMD as recently as Q4 2025.

Faithward Advisors first reported a position in RMD in Q4 2019 and has held it in 19 quarters since. The position peaked at $5.14M in Q2 2020. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Faithward Advisors held 1,160 shares of ResMed worth $226K as of Q2 2026.
  • ResMed was a new Faithward Advisors position in Q2 2026.
  • ResMed made up 0.03% of Faithward Advisors's portfolio in Q2 2026, its #314 holding.
  • Faithward Advisors first reported a position in ResMed in Q4 2019 and has held it in 19 quarters since.
  • Faithward Advisors's ResMed position peaked at $5.14M in Q2 2020.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Faithward Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.